Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program (2008)

Chapter: 2 Antiviral Effectiveness, Safety, and Supply

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF.

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter: 1 Introduction
Page 19 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 19
Page 20 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 20
Page 21 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 21
Page 22 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 22
Page 23 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 23
Page 24 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 24
Page 25 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 25
Page 26 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 26
Page 27 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 27
Page 28 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 28
Page 29 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 29
Page 30 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 30
Page 31 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 31
Page 32 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 32
Page 33 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 33
Page 34 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 34
Page 35 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 35
Page 36 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 36
Page 37 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 37
Page 38 Cite
Suggested Citation: "2 Antiviral Effectiveness, Safety, and Supply." Institute of Medicine. 2008. Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press. doi: 10.17226/12170.
Save
Cancel
Page 38
Next Chapter: 3 Ethics, Decision Making, and Communication
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.